Abstract
Elevated interleukin-6 (IL-6) levels are linked to worse outcomes in patients with COVID-19, but it remains unclear whether blocking this cytokine
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
